
Loading, please wait...

Loading, please wait...

Clinicians recently identified a unique case involving a 59-year-old man with progressive, painless right blepharoptosis over three months. This condition initially appeared as simple poor levator function, yet imaging revealed a much more complex pathology. Magnetic resonance imaging (MRI) demonstrated isolated enlargement of the right levator palpebrae superioris (LPS). Crucially, the superior rectus and other extraocular muscles remained unaffected. This specific finding served as the sole harbinger for primary orbital lymphoma.
The radiological evaluation provided essential clues for the diagnosis. The enlarged muscle appeared isointense on both T1 and T2-weighted images. Furthermore, it showed homogenous contrast enhancement and a low apparent diffusion coefficient (ADC) on diffusion-weighted MRI. These imaging characteristics often suggest hypercellularity, which is typical of lymphoid tumors. To confirm the diagnosis, the medical team performed an incisional biopsy via an upper lid skin crease incision. The histopathology revealed a low-grade B-cell non-Hodgkin lymphoma. Specifically, the immunophenotype was consistent with extranodal marginal zone lymphoma, a common subtype of primary orbital lymphoma.
Systemic staging is vital for patients diagnosed with orbital malignancies. In this case, staging showed no extraorbital disease, confirming the localized nature of the tumor. Consequently, the patient proceeded with localized orbital radiotherapy. At the 3-month follow-up, the patient achieved complete resolution of the ptosis and the muscular enlargement. This outcome underscores the importance of early detection through advanced imaging. Moreover, it highlights that isolated muscle involvement, while rare, must remain on the differential diagnosis list for orbital masses.
The authors of this case emphasize the critical role of diffusion-weighted MRI (DWI) when investigating single muscle enlargement. Low ADC values are particularly suggestive of lymphoma because the high cellular density restricts water diffusion. While thyroid eye disease or idiopathic orbital inflammation more commonly cause muscle enlargement, clinicians should maintain high suspicion for primary orbital lymphoma when imaging displays these specific characteristics. Therefore, localized radiotherapy remains a highly effective treatment for these marginal zone B-cell lymphomas.
It often presents as a painless, slowly progressive mass or swelling in the orbit. In rare cases, it can cause isolated muscle enlargement leading to symptoms like ptosis or double vision.
Diffusion-weighted MRI helps differentiate between various orbital lesions. A low apparent diffusion coefficient (ADC) indicates high cellularity, which strongly points toward a diagnosis of lymphoma rather than inflammation.
Localized low-dose radiotherapy is the standard treatment and usually results in excellent local control and high rates of complete resolution.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Agarwal A et al. Isolated levator palpebrae superioris enlargement as the sole harbinger of primary orbital lymphoma. Orbit. 2026 Apr 08. doi: 10.1080/01676830.2026.2654187. PMID: 41949897.
Valvassori GE, et al. Lymphoma of the orbit and adnexa. Neuroimaging Clin N Am. 1996;6(1):137-54.
Polito E, et al. Primary adnexal B-cell lymphomas: a clinical and prognostic study of 17 cases. Graefes Arch Clin Exp Ophthalmol. 2002;240(10):837-44.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A rare case report of a 59-year-old man where isolated enlargement of the levator palpebrae superioris was the only indicator of primary orbital lymphoma....
5 months ago

A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today

Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today